Zobrazeno 1 - 10
of 236
pro vyhledávání: '"VCE-004.8"'
Autor:
García-Martín, Adela1,2,3 (AUTHOR) bc2gamam@uco.es, Prados, María E.1,2,3 (AUTHOR), Lastres-Cubillo, Isabel1,3 (AUTHOR), Ponce-Diaz, Francisco J.1,2,3 (AUTHOR), Cerero, Laura1,2,3 (AUTHOR), Garrido-Rodríguez, Martin4 (AUTHOR), Navarrete, Carmen1,3 (AUTHOR), Pineda, Rafael1,2,3 (AUTHOR), Rodríguez, Ana B.1,2,3 (AUTHOR), Muñoz, Ignacio1,3 (AUTHOR), Moya, Javier1,3 (AUTHOR), Medeot, Antonella1,3 (AUTHOR), Moreno, José A.1,3 (AUTHOR), Chacón, Antonio1,3 (AUTHOR), García-Revillo, José1,3 (AUTHOR), Muñoz, Eduardo1,2,3 (AUTHOR) fi1muble@uco.es
Publikováno v:
Journal of Translational Medicine. 11/6/2024, Vol. 22 Issue 1, p1-24. 24p.
Autor:
Adela García-Martín, María E. Prados, Isabel Lastres-Cubillo, Francisco J. Ponce-Diaz, Laura Cerero, Martin Garrido-Rodríguez, Carmen Navarrete, Rafael Pineda, Ana B. Rodríguez, Ignacio Muñoz, Javier Moya, Antonella Medeot, José A. Moreno, Antonio Chacón, José García-Revillo, Eduardo Muñoz
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-24 (2024)
Abstract Background Vasculogenic therapies explored for the treatment of peripheral artery disease (PAD) have encountered minimal success in clinical trials. Addressing this, B55α, an isoform of protein phosphatase 2A (PP2A), emerges as pivotal in v
Externí odkaz:
https://doaj.org/article/da0c42d747b54ca685b4758f5f0eacbf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lavayen, Bianca P., Yang, Changjun, Larochelle, Jonathan, Liu, Lei, Tishko, Ryland J., de Oliveira, Antonio Carlos Pinheiro, Muñoz, Eduardo, Candelario-Jalil, Eduardo
Publikováno v:
In Neurochemistry International May 2023 165
Autor:
Palomares, Belen1,2,3 (AUTHOR), Ruiz-Pino, Francisco1,2,3 (AUTHOR), Navarrete, Carmen4 (AUTHOR), Velasco, Inmaculada1,2,3 (AUTHOR), Sánchez-Garrido, Miguel A.1,2,3 (AUTHOR), Jimenez-Jimenez, Carla1,2,3 (AUTHOR), Pavicic, Carolina5 (AUTHOR), Vazquez, Maria J.1,2,3 (AUTHOR), Appendino, Giovanni6 (AUTHOR), Bellido, M. Luz4,7 (AUTHOR), Calzado, Marco A.1,2,3 (AUTHOR), Tena-Sempere, Manuel1,2,3 (AUTHOR), Muñoz, Eduardo1,2,3 (AUTHOR) fi1muble@uco.es
Publikováno v:
Scientific Reports. 10/31/2018, Vol. 8 Issue 1, p1-15. 15p.
Autor:
García-Martín, Adela, Garrido-Rodríguez, Martín, Navarrete, Carmen, del Río, Carmen, Bellido, María L., Appendino, Giovanni, Calzado, Marco A., Muñoz, Eduardo
Publikováno v:
In Biochemical Pharmacology November 2018 157:304-313
Autor:
Sonia Burgaz, Concepción García, María Gómez-Cañas, Alain Rolland, Eduardo Muñoz, Javier Fernández-Ruiz
Publikováno v:
Molecules, Vol 26, Iss 11, p 3245 (2021)
The 3-hydroxyquinone derivative of the non-psychotrophic phytocannabinoid cannabigerol, so-called VCE-003.2, and some other derivatives have been recently investigated for neuroprotective properties in experimental models of Parkinson’s disease (PD
Externí odkaz:
https://doaj.org/article/55142c8699664604a79734d5d10264a8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Carmen Navarrete, Francisco Carrillo-Salinas, Belén Palomares, Miriam Mecha, Carla Jiménez-Jiménez, Leyre Mestre, Ana Feliú, Maria L. Bellido, Bernd L. Fiebich, Giovanni Appendino, Marco A. Calzado, Carmen Guaza, Eduardo Muñoz
Publikováno v:
Journal of Neuroinflammation, Vol 15, Iss 1, Pp 1-19 (2018)
Abstract Background Multiple sclerosis (MS) is characterized by a combination of inflammatory and neurodegenerative processes variously dominant in different stages of the disease. Thus, immunosuppression is the goal standard for the inflammatory sta
Externí odkaz:
https://doaj.org/article/2126d9a3cc894214894db216f8403311
Autor:
Javier Fernández-Ruiz, Eduardo Muñoz, Concepción García, Alain Rolland, Sonia Burgaz, María Gómez-Cañas
Publikováno v:
Molecules
Volume 26
Issue 11
Molecules, Vol 26, Iss 3245, p 3245 (2021)
Volume 26
Issue 11
Molecules, Vol 26, Iss 3245, p 3245 (2021)
The 3-hydroxyquinone derivative of the non-psychotrophic phytocannabinoid cannabigerol, so-called VCE-003.2, and some other derivatives have been recently investigated for neuroprotective properties in experimental models of Parkinson’s disease (PD